BR9706967A - Use of compounds and process for treatment and prophylaxis of symptoms related to menopause - Google Patents

Use of compounds and process for treatment and prophylaxis of symptoms related to menopause

Info

Publication number
BR9706967A
BR9706967A BR9706967A BR9706967A BR9706967A BR 9706967 A BR9706967 A BR 9706967A BR 9706967 A BR9706967 A BR 9706967A BR 9706967 A BR9706967 A BR 9706967A BR 9706967 A BR9706967 A BR 9706967A
Authority
BR
Brazil
Prior art keywords
menopause
prophylaxis
compounds
treatment
symptoms related
Prior art date
Application number
BR9706967A
Other languages
Portuguese (pt)
Inventor
Michael Shalmi
Niels Korsgaard
Birgitte Hjort Gudlhammer
James Robinson Piggott
Virender Mohan Labroo
Steven Bain
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9706967A publication Critical patent/BR9706967A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
BR9706967A 1996-01-11 1997-01-09 Use of compounds and process for treatment and prophylaxis of symptoms related to menopause BR9706967A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US983496P 1996-01-11 1996-01-11
US67826196A 1996-07-11 1996-07-11
PCT/DK1997/000008 WO1997025035A1 (en) 1996-01-11 1997-01-09 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms

Publications (1)

Publication Number Publication Date
BR9706967A true BR9706967A (en) 1999-05-04

Family

ID=26679921

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9706967A BR9706967A (en) 1996-01-11 1997-01-09 Use of compounds and process for treatment and prophylaxis of symptoms related to menopause

Country Status (12)

Country Link
EP (1) EP0873120A1 (en)
JP (1) JP2000506505A (en)
KR (1) KR19990077156A (en)
AU (1) AU1367297A (en)
BR (1) BR9706967A (en)
CA (1) CA2241623A1 (en)
CZ (1) CZ217298A3 (en)
HU (1) HUP9902683A3 (en)
IL (1) IL124882A0 (en)
NO (1) NO983178L (en)
PL (1) PL327831A1 (en)
WO (1) WO1997025035A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
DE60018215T2 (en) * 1999-12-30 2006-02-09 Signal Pharmaceuticals Llc, San Diego COMPOUNDS AND METHOD FOR MODULATING ESTROGEN RECEPTORS
CN101056868B (en) 2004-09-21 2012-05-02 马休爱德华兹股份有限公司 Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CN102357248A (en) 2004-10-20 2012-02-22 恩多研究公司 Sex steroid precursor alone or in combination with a selective estrogen receptor modulator for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
CA2702710C (en) 2007-10-16 2013-05-07 Repros Therapeutics, Inc. Trans-clomiphene for metabolic syndrome
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
BR112012032189B1 (en) 2010-06-16 2020-11-03 Endorecherche, Inc uses of an lhrh agonist or antagonist in combination with a selective estrogen receptor modulator and a sex steroid precursor for the preparation of a drug for the treatment or prevention of estrogen-related diseases and kits
JP6013349B2 (en) 2010-11-01 2016-10-25 メイ ファーマ, インク.Mei Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
CA2865234A1 (en) 2012-02-29 2013-09-06 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
EP2953938B1 (en) 2014-02-07 2017-08-02 Novogen Ltd. Functionalised benzopyran compounds and use thereof
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
HUE054998T2 (en) 2015-02-02 2021-10-28 Mei Pharma Inc Combination therapies for use in the treatment of breast cancer
AU2016352592B2 (en) 2015-11-10 2023-04-27 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency

Also Published As

Publication number Publication date
HUP9902683A2 (en) 2001-04-28
WO1997025035A1 (en) 1997-07-17
KR19990077156A (en) 1999-10-25
AU1367297A (en) 1997-08-01
HUP9902683A3 (en) 2001-08-28
CA2241623A1 (en) 1997-07-17
JP2000506505A (en) 2000-05-30
CZ217298A3 (en) 1999-01-13
IL124882A0 (en) 1999-01-26
EP0873120A1 (en) 1998-10-28
NO983178L (en) 1998-07-10
PL327831A1 (en) 1999-01-04

Similar Documents

Publication Publication Date Title
BR9706967A (en) Use of compounds and process for treatment and prophylaxis of symptoms related to menopause
BR9400571A (en) Process for the treatment of organic waste
PT712860E (en) PROCESS FOR PURIFICATION AND ISOLATION OF 2'-DEOXY-2 ', 2'-DIFLUORONUCLEOSIDOS
BR9408148A (en) Process for the treatment of compound arrhythmia and pharmaceutical formulation
BR9503624A (en) Process of preparation of aromatic compounds
BR9408407A (en) Use of pla2 inhibitors as treatment for alzheimer's disease
BR9305274A (en) Process for treating raw milk
BR9400177A (en) Process and device for evacuation of solid waste
BR9204375A (en) COMPOSITION AND PROCESS FOR THE REFRIGERATION WATER TREATMENT
BR9708093A (en) Compound compound use formulation and process for treating 5-hydroxytryptamine-mediated disorders and for compound preparation
BR9506473A (en) Compound process for the preparation of compounds use of a compound pharmaceutical composition and process for the treatment of anti-fungal infections
BR9506271A (en) Process for the treatment of poultry
BR9400368A (en) Process for isolation and purification of trehalose
PT96725A (en) PROCESS FOR THE TREATMENT OF COCOA GRAINS
BR9708908A (en) Process for treating inflammation
BR9607346A (en) Compound use of a compound, pharmaceutical composition and process for the treatment of a mammal and for and preparation of compounds
BR9106377A (en) COMPOSITION AND PROCESS FOR TOPICAL TREATMENT OF INJURED OR NURSING TISSUE
BR9505700A (en) Process for and continuous preparation of organic isocyanates
PT1345944E (en) PROCESS FOR THE ISOLATION AND PURIFICATION OF EPOTILONAS
BR9602657A (en) Process for the treatment of red mud bauxite residue and disposal of red mud residue
PT1068162E (en) PROCESS FOR REMOVAL OF IMPURITIES OF CAULIN CLAYS
BR9606766A (en) Use of compounds and process for the treatment and prophylaxis of degenerative brain disorders
BR9502184A (en) Topical cosmetic compositions use of compositions cosmetic treatment process
BR9002081A (en) PROCESS AND APPARATUS FOR THE TREATMENT OF ORGANIC DETRITES
BR9606925A (en) Use of compounds and process for the treatment and prophylaxis of obesity

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]